Profil
Ake P.
Elhammer is the founder of AureoGen, Inc. (founded in 2003) and serves as the Chief Executive Officer since 2011.
Currently, Dr. Elhammer holds the position of Professor at Western Michigan University.
Previously, Dr. Elhammer worked as a Principal at The Upjohn Co. and Kabigen AB. Dr. Elhammer obtained undergraduate and doctorate degrees from the University of Stockholm.
Postes actifs de Ake P. Elhammer
| Sociétés | Poste | Début |
|---|---|---|
Western Michigan University
Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 08/02/2010 |
Anciens postes connus de Ake P. Elhammer
| Sociétés | Poste | Fin |
|---|---|---|
The Upjohn Co.
The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Corporate Officer/Principal | - |
Kabigen AB | Corporate Officer/Principal | - |
AureoGen, Inc.
AureoGen, Inc. BiotechnologyHealth Technology Develops a novel genetic-engineering technolgy for the discovery and production of cyclic peptide based drugs | Directeur Général | - |
Formation de Ake P. Elhammer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Upjohn Co.
The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Western Michigan University
Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AureoGen, Inc.
AureoGen, Inc. BiotechnologyHealth Technology Develops a novel genetic-engineering technolgy for the discovery and production of cyclic peptide based drugs | Health Technology |
Kabigen AB |
















